The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Vertex Pharmaceuticals Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Designation or determination (2) Designation or determination (2) Date 2020 (2) (-) 2020 (2) 2025 (2) 2025 (2) 2024 (7) 2024 (7) 2023 (3) 2023 (3) 2022 (4) 2022 (4) 2021 (6) 2021 (6) 2019 (8) 2019 (8) 2018 (3) 2018 (3) 2017 (1) 2017 (1) 2016 (4) 2016 (4) 2013 (3) 2013 (3) Show more Search Filters applied:2020Clear all Sponsor content2 result(s) found, displaying 1 to 2 Notice for ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd) 3 July 2020 Designation or determination Orphan drug Notice for tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd) 17 February 2020 Designation or determination Orphan drug
Notice for ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd) 3 July 2020 Designation or determination Orphan drug
Notice for tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd) 17 February 2020 Designation or determination Orphan drug